• May 29, 2019
    Zoetis’ African Livestock Productivity and Health Advancement (A.L.P.H.A.) initiative, which aims to improve livestock health and positively impact farmers’ livelihoods in sub-Saharan Africa, is increasing access to animal health education and infrastructure in its second year. Following the success of A.L.P.H.A. in Uganda, Nigeria and Ethiopia, the initiative was extended by two years, and will now run until 2022. It was also geographically expanded into Tanzania. The initiative has alsomore...
  • November 26, 2018
    PROHEALTH, the largest European Commission-funded livestock agriculture research project, culminated today having identified the most common and costly health threats and potential solutions to sustainable livestock production.The project focused on disease threats associated with the intensity of production in swine herds and poultry flocks and recommended innovative prediction, prevention and detection solutions to improve animal health and increase productivity, while limiting environmentalmore...
  • August 22, 2018
    PHARMAQ, a business of the leading global animal health company Zoetis, today announced a long-term strategic partnership agreement with Vinh Hoan, the world’s leading producer and exporter of pangasius with headquarters in Vietnam. The agreement was signed during the VIETFISH Exhibition in Ho Chi Minh City by Mrs. Truong Thi Le Khanh, Chairwoman of Vinh Hoan, and Mr. Morten Nordstad, President of PHARMAQ The ceremony was attended by Mr. Vũ Văn Tám, Deputy Minister of the Ministry ofmore...
  • April 23, 2018
    Zoetis today reported on progress during the first year of its African Livestock Productivity and Health Advancement initiative (A.L.P.H.A.) to establish sustainable veterinary diagnostic networks and animal health infrastructure in Uganda, Nigeria, and Ethiopia. The initiative, funded by a $14.4 million grant from the Bill & Melinda Gates Foundation, aims ultimately to improve livestock health and positively impact farmers’ livelihoods in sub-Saharan Africa.In year one of this three-yearmore...
  • May 8, 2017
    PARSIPPANY, N.J.--(BUSINESS WIRE)--Zoetis Inc. (NYSE:ZTS), the largest global animal health company, announced it will receive a US$14.4 million grant from the Bill & Melinda Gates Foundation over the next three years to develop veterinary diagnostic networks and animal health infrastructure in Ethiopia, Nigeria and Uganda. The grant will enable Zoetis to develop veterinary laboratory networks and outreach services to increase the availability of localmore...
  • January 3, 2017
    OSLO, NORWAY – Jan. 3, 2017 - PHARMAQ, a business of Zoetis, today announced the acquisition of the Norwegian  company Nordland Sett Vaks, an innovator in the manufacture and marketing of high quality vaccination machinery for the aquaculture industry. Nordland Sett Vaks is based in Nesna, Norway, and offers a wide range of fish vaccination services and sale of vaccination machines to fish farming companies in Norway, the UK and in the Mediterranean region. Terms of the transaction weremore...
  • April 28, 2016
    GUILDFORD, SURREY, UK - April 27, 2016 - Zoetis and the University of Surrey today launched the Veterinary Health Innovation Engine (vHive), a novel multi-disciplinary centre designed to promote the development and adoption of digital innovation in animal health.Digital technologies including wearables, apps, sensors and satellites promise to transform real-time information capture for animal owners and their veterinary advisors.  This will enable improved understanding of animal healthmore...
  • March 30, 2016
    FLORHAM PARK, N.J., March 30, 2016 — Zoetis Inc. today announced that the U.S. Department of Agriculture (USDA) has granted the company a conditional license for Avian Influenza Vaccine, H5N1 Subtype, Killed Virus*. The vaccine is intended for use in chickens as an aid in the prevention of disease caused by avian influenza H5N1.“We stand ready to help our customers implement a vaccination strategy, should the USDA determine that is the best course of action for the industry,” said Jonmore...
  • November 10, 2015
    FLORHAM PARK, N.J.--(BUSINESS WIRE)--Zoetis Inc. (NYSE:ZTS) today announced that it has completed the purchase of PHARMAQ, the global leader in vaccines and innovation for health products in aquaculture, for a price of $765 million on a debt-free basis, having fulfilled all closing requirements. Zoetis purchased PHARMAQ from a company owned by Permira IV, a fund managed by the global investment firm Permira, which has been the majority owner of the companymore...
  • November 2, 2015
    FLORHAM PARK, N.J.--(BUSINESS WIRE)--Zoetis Inc. (NYSE:ZTS) today announced an agreement to purchase PHARMAQ, the global leader in vaccines and innovation for health products in aquaculture, for a price of $765 million on a debt-free basis. Acquiring PHARMAQ strengthens Zoetis’ core livestock business, giving the company a market-leading presence in the fastest growing segment of the animal health industry. Zoetis is purchasing PHARMAQ from a company owned by Permira IV, amore...